Open access
Aug 2026
Development of an investigational medicinal stem cell gene therapy product to attempt curing human immunodeficiency virus infection
This work proposes to test an alternative strategy, namely expression of a designer recombinase which specifically excises HIV provirus from the genome under a Tat-inducible promoter so that expression is restricted to infected cells.
Laura Weigand, S. Herkt, Maike Voges et al.
· Scientific Reports · 0 citations